Cellular Origins is revolutionizing cell therapy manufacturing with a flexible, robotic end-to-end automation platform called Constellation. The system integrates proven tools and processes to scale CGT manufacturing, enabling GMP-compliant, fully automated production. The company operates from the UK, including its TTP Campus in Melbourn and Cambridge region, collaborating with technology partners to industrialise and digitise cell therapy workflows for wider patient access.